Cargando…
Fragment Length of Circulating Tumor DNA
Malignant tumors shed DNA into the circulation. The transient half-life of circulating tumor DNA (ctDNA) may afford the opportunity to diagnose, monitor recurrence, and evaluate response to therapy solely through a non-invasive blood draw. However, detecting ctDNA against the normally occurring back...
Autores principales: | Underhill, Hunter R., Kitzman, Jacob O., Hellwig, Sabine, Welker, Noah C., Daza, Riza, Baker, Daniel N., Gligorich, Keith M., Rostomily, Robert C., Bronner, Mary P., Shendure, Jay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948782/ https://www.ncbi.nlm.nih.gov/pubmed/27428049 http://dx.doi.org/10.1371/journal.pgen.1006162 |
Ejemplares similares
-
Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing
por: Hellwig, Sabine, et al.
Publicado: (2018) -
Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?
por: Underhill, Hunter R.
Publicado: (2021) -
In vitro, long-range sequence information for de novo genome assembly via transposase contiguity
por: Adey, Andrew, et al.
Publicado: (2014) -
The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA
por: Nix, David A., et al.
Publicado: (2020) -
Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition
por: Adey, Andrew, et al.
Publicado: (2010)